FDX
40
4
PNR
62
2
BWA
45
3
PRGO
36
3
SBUX
39
3
HCP
54
-2
MAC
58
4
GOOG
81
-2
AAPL
65
-2
NTRS
47
3
OI
30
5
CFG
44
4
WBA
44
6
ORLY
48
-4
JCI
44
2
NOC
43
2
YUM
45
2
TXT
48
2
VFC
58
2
ROP
50
2
FDX
40
4
PNR
62
2
BWA
45
3
PRGO
36
3
SBUX
39
3
HCP
54
-2
MAC
58
4
GOOG
81
-2
AAPL
65
-2
NTRS
47
3
OI
30
5
CFG
44
4
WBA
44
6
ORLY
48
-4
JCI
44
2
NOC
43
2
YUM
45
2
TXT
48
2
VFC
58
2
ROP
50
2
Financhill
Back

Enact Holdings Vs. Aligos Therapeutics Industry Stock Comparison

Sell
27

ACT
Enact Holdings

Last Price:
$32.38
Seasonality Move:
2.66%
Buy
65

ALGS
Aligos Therapeutics

Last Price:
$41.28
Seasonality Move:
-16.03%
Sell
27
Enact Holdings (ACT) is a Sell

Is Enact Holdings a Buy, Sell or Hold?

  • The current Enact Holdings [ACT] share price is $32.91. The Score for ACT is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • ACT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
65
Aligos Therapeutics (ALGS) is a Buy

Is Aligos Therapeutics a Buy, Sell or Hold?

  • The current Aligos Therapeutics [ALGS] share price is $43.37. The Score for ALGS is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
  • ALGS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

ACT Stock Price Chart

What is Enact Holdings's stock price today?

  • The Enact Holdings share price today is $32.91
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ACT is experiencing buying pressure, which is a positive indicator for future bullish movement.

ALGS Stock Price Chart

What is Aligos Therapeutics's stock price today?

  • The Aligos Therapeutics share price today is $43.37
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.

ACT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.53 Sell
Relative Strength Index (14 RSI): 36.51 Sell
Chaikin Money Flow: 104060 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.25 - 35.25) Sell
Bollinger Bands (100): (33.65 - 36.09) Sell

ALGS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.71 Buy
Relative Strength Index (14 RSI): 81.52 Buy
Chaikin Money Flow: 630913 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (22.74 - 36.8) Buy
Bollinger Bands (100): (6.83 - 25.23) Buy

ACT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 33.04 Sell
20-day SMA: 34.13 Sell
50-day SMA: 34.41 Sell
200-day SMA: 32.91 Buy
8-day EMA: 33.09 Sell
20-day EMA: 33.72 Sell
50-day EMA: 34.26 Sell
200-day EMA: 32.92 Sell

ALGS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 37.61 Buy
20-day SMA: 32.22 Buy
50-day SMA: 20.6 Buy
200-day SMA: 16.51 Buy
8-day EMA: 38.12 Buy
20-day EMA: 32.66 Buy
50-day EMA: 24.43 Buy
200-day EMA: 18.11 Buy

Enact Holdings Earnings Growth & ACT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.23 per share.

Aligos Therapeutics Earnings Growth & ALGS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.

Enact Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Aligos Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):